VIASURE
LIVE

Serial Number

79451805

Owner

CERTEST BIOTEC, S.L.

Filing Date

Apr 24, 2026

Add to watchlist:

No watchlists yet
View on USPTO

VIASURE Trademark

Serial Number: 79451805

VIASURE is a trademark filed by CERTEST BIOTEC, S.L. on April 24, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

CERTEST BIOTEC, S.L. (2 trademarks)

Polígono Industrial Río Gállego II,

Entity Type: 99

Trademark Details

Filing Date

April 24, 2026

Registration Date

Not Registered

Goods & Services

Diagnostic agents for medical and pharmaceutical use; products for medical diagnosis; indicators for medical diagnosis; diagnostic testing materials for medical use; in-vitro diagnostic preparations for medical use; diagnostic preparations for medical or veterinary use; diagnostic reagents for medical use; clinical diagnostic reagents; medical diagnostic test strips; medicinal preparations for infectious disease treatment; reagents for use in diagnostic tests for medical purposes; radioisotope markers for therapeutic or diagnostic use; antigens; chemical preparations for medical use; tumor antigens; immunotherapeutic agents for bacterial infections; vaccines; adjuvants for vaccines; disinfectants; clinical diagnostics for medical or veterinary use; plasters, material for dressings; fungicides, herbicides; teeth filling and dental impression materials; biological, bacterial, biochemical, chemical and enzyme preparations for medical use; sanitary preparations and products thereof; medicinal preparations and substances; oral vaccine preparations; pharmaceutical and veterinary products; hygienic and sanitary products for medical use; medical products; products for medical and veterinary diagnosis; products for destroying vermin; sanitary products for in-vitro diagnosis; diagnostic products and materials; veterinary diagnostic reagents; assay reagents for medical diagnosis; reagents for medical research applications (for diagnosis); reagents for clinical and medical diagnosis; reagents for use with analyzers for medical purposes; reagents for in-vitro medical diagnostic use; reagents for in-vitro use in laboratories for medical purposes; reagents for medical use; chemical diagnostic reagents for medical use; pharmaceutical products and preparations for medical use; diagnostic preparations for medical use; diagnostic substances for medical use; diagnostic test kits comprising diagnostic reagents and tests for body fluid analysis; none of the aforementioned products for dietetic or nutritional purposes.

Automatic analyzers for medical diagnosis; automatic analyzers for body fluids [for medical use]; analyzers for medical use; equipment for analysis of microbiological organisms, infections, tumor markers, cardiac markers; equipment for diagnosis, examination and monitoring; medical and diagnostic devices, apparatus and instruments; instruments for quantitative Polymerase Chain Reaction (PCR) for medical use.

Scientific apparatus and instruments; apparatus for scientific and laboratory research; equipment and accessories for data processing (electrical or mechanical); analytical instruments for quantitative Polymerase Chain Reaction (PCR); diagnostic testing apparatus for tests; diagnostic testing apparatus for scientific and research tests; analytical instruments for real-time Polymerase Chain Reaction (PCR); scientific research and laboratory apparatus, in particular, automation equipment and sequencing equipment; programs for data analysis; software; scientific software; collaborative software; support software; remote diagnostic software; data processing software; downloadable software; software for managing computer data and files and databases; software for use in systems supporting medical decision making; software for clinical sample traceability; software for interpreting results; software for commercial use.

Filing History

ASSIGNED TO EXAMINER
Jun 13, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 12, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 11, 2026 REPR